Brief: Viracta Therapeutics Reports Q4 And Full Year 2022 Financial Results And Provides A Corporate Update

Viracta Therapeutics

13/03/2023 20:27

March 13 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
    * CASH, CASH EQUIVALENTS AND INVESTMENTS OF $91.0 MILLION AS
OF
DECEMBER 31, 2022; ANTICIPATED CASH RUNWAY INTO LATE 2024
    * NET LOSS WAS APPROXIMATELY $10.3 MILLION, OR $0.27 PER
SHARE
(BASIC AND DILUTED) FOR QUARTER ENDED DECEMBER 31, 2022
    * Q4 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8gY9YW 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))